Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01708447 · ClinicalTrials.gov registry record · NA

Feasibility Study: Evaluate the Effectiveness of Using a Topical Anesthetic Prior to Ultherapy™ Treatment

A NA study, sponsored by Ulthera.

Completed
Registry status
NA
Development phase
16
Enrollment target

NCT01708447: Completed NA study, sponsored by Ulthera.

NCT01708447 is a NA study that has completed, run by Ulthera. The registered enrollment target is 16 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01708447, a NA study, has completed, sponsored by Ulthera.

COMPLETED
Registry status
NA
Development phase
16 participants
Enrollment target

Study Summary

This study will evaluate the efficacy of a lidocaine topical anesthetic (numbing cream) for reducing discomfort associated with Ultherapy™ treatment.

Primary Outcome

The validated 10-point pain NRS scale will be used to measure average pain scores reported by subject immediately after each facial region is treated.

Interventions

  • DEVICE Ulthera System Treatment
  • DRUG L.M.X.4.® cream
  • OTHER A placebo cream

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2011-07
Est. Completion 2012-01
Phase NA
Ulthera

42 total trials

What the finished NCT01708447 record still lists

NCT01708447 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 3 interventions - of which Ulthera System Treatment is the first listed.

NCT01708447 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01708447 about?

NCT01708447 is a clinical study titled "Feasibility Study: Evaluate the Effectiveness of Using a Topical Anesthetic Prior to Ultherapy™ Treatment". This study will evaluate the efficacy of a lidocaine topical anesthetic (numbing cream) for reducing discomfort associated with Ultherapy™ treatment.

What is the current status of trial NCT01708447?

This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2011-07. Estimated completion is 2012-01.

What interventions are being tested in trial NCT01708447?

The interventions under investigation include: Ulthera System Treatment (DEVICE), L.M.X.4.® cream (DRUG), A placebo cream (OTHER).

Who is sponsoring clinical trial NCT01708447?

This trial is sponsored by Ulthera, which has 42 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01708447's enrollment target sits among peer trials

16 1871st of 2000 higher than 120 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02422641 · 16 participants · Phase 2

    Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

  • NCT02851758 · 16 participants · NA

    Transplantation of Autologously Derived Mitochondria Following Ischemia

  • NCT03291028 · 16 participants

    Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

  • NCT03425526 · 16 participants · Phase 1

    Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01708447, the US trial registry maintained by the National Library of Medicine. NCT01708447 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.